Sort
30,917 grants matching “tumor microenvironment”
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
$627,063Susan L. Neuhausen · Beckman Research Institute/City Of Hope · R01 · FY2024 · ES
Oncolytic HSV Immunovirotherapy for brain tumors
$627,061Robert L Martuza · Massachusetts General Hospital · R01 · FY2024 · CA
Stimulation of Tumorigenesis by NKG2D
$627,023Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer
$626,956Lin Z Li · University Of Pennsylvania · R01 · FY2024 · CA
The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes
$626,952Steve Onyeka Oghumu · Ohio State University · R01 · FY2024 · DE
The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes
$626,952Steve Onyeka Oghumu · Ohio State University · R01 · FY2025 · DE
Recruitment of Stromal Cells to the Tumor Microenvironment
$626,899Robert A Weinberg · Massachusetts Institute Of Technology · U54 · FY2009 · CA
Defining the landscape of bacterial-colonized microniches in tumors and their role in intratumoral heterogeneity.
$626,893Susan Bullman · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2023 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2022 · CA
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles
$626,777Cristina L. Zavaleta · University Of Southern California · R01 · FY2025 · CA
Mouse models of Kras-mutant colorectal cancer
$626,771Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Mouse models of Kras-mutant colorectal cancer
$626,771Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
$626,746Melissa Lambeth Kemp · Georgia Institute Of Technology · U01 · FY2021 · CA
Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer
$626,716Jered C Garrison · University Of Nebraska Medical Center · R01 · FY2025 · CA
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
$626,640Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2023 · CA
Matrix Organization and Dimensionality
$626,550Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
Dissecting the Mechanism for Transient ER Stress-Induced Anti-Tumor T Cell Response
$626,534Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2025 · CA
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$626,526Daniel J. Powell · University Of Pennsylvania · R01 · FY2024 · CA
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
$626,484Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Mechanobiology
$626,432Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2022 · EB
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
$626,352Catherine C Park · University Of California, San Francisco · R01 · FY2016 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer
$626,197Andrew T Chan · Massachusetts General Hospital · R01 · FY2021 · CA
The tumor ecosystem in cancer progression and immunotherapeutic response
$625,935Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2018 · CA
Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers
$625,929Karen L. Abbott · Florida International University · U01 · FY2021 · CA